OMNIPOD INSULIN PUMP
Report
- Report Number
- 3004464228-2013-00766
- Event Type
- Malfunction
- Date Received
- July 15, 2013
- Date of Event
- June 13, 2013
- Report Date
- June 17, 2013
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- PMA / PMN Number
- K042792
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
THE DEVICE WAS NOT RETURNED FOR EVALUATION. WE ARE UNABLE TO DETERMINE IF ANY MALFUNCTION COULD HAVE CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. THE CUSTOMER REPORTED THAT THE CANNULA DID NOT INSERT PROPERLY. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. LOT QUALIFICATION RECORDS WERE REVIEWED, AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD USER GUIDE WARNS, "CHECK THE INFUSION SITE AFTER INSERTION TO ENSURE THAT THE CANNULA WAS PROPERLY INSERTED. IT IS ALSO A GOOD IDEA TO CHECK YOUR BLOOD GLUCOSE ABOUT TWO HOURS AFTER EACH POD CHANGE AND TO CHECK THE INFUSION SITE PERIODICALLY. IF THE CANNULA IS NOT PROPERLY INSERTED, HYPERGLYCEMIA MAY RESULT" AND "TEST RESULTS GREATER THAN 250 MG/DL MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). IF YOU GET RESULTS ABOUT 250 MG/DL, BUT DO NOT HAVE SYMPTOMS OF HYPERGLYCEMIA, REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL ABOVE 250 MG/DL, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER."
THE CUSTOMER REPORTED THAT SHE ACTIVATED A POD AND GAVE HERSELF A .5U BOLUS AT 6:35 AM ON (B)(6). SHE PROVIDED THE FOLLOWING HISTORY: TIME: 9:11 AM, BG RESULT: 155 MG/DL, CARBOHYDRATE: 77 GRAMS, BOLUS: 0.85U, 7.70U; TIME: 10:36 AM, BG RESULT: 488 MG/DL, BOLUS: 7.10U; TIME: 12:02 PM, BG RESULT: 464 MG/DL, BOLUS: 7U (MANUAL INJECTION). AT 3:44 PM, WITH A RESULT OF 469 MG/DL, SHE DEACTIVATED THE POD. WHEN SHE REMOVED IT, SHE NOTICED THAT THE CANNULA HAD NEVER INSERTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 328012 | OMNIPOD INSULIN PUMP | PUMP, INFUSION, INSULIN | LZG | INSULET CORPORATION | 11200 | L31097 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 30 YR |